SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001214659-24-009731
Filing Date
2024-05-22
Accepted
2024-05-22 09:23:39
Documents
5
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 r5212406k.htm 6-K 22566
2 EXHIBIT 4.1 ex4_1.htm EX-4.1 124642
3 EXHIBIT 4.2 ex4_2.htm EX-4.2 124926
4 EXHIBIT 10.1 ex10_1.htm EX-10.1 56048
5 EXHBIIT 99.1 ex99_1.htm EX-99.1 18935
  Complete submission text file 0001214659-24-009731.txt   348287
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37652 | Film No.: 24971776
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)